product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Mouse anti Mouse Notch 1:RPE
catalog :
MCA2410PE
quantity :
100 Tests
price :
455 USD
clonality :
monoclonal
host :
mouse
conjugate :
RPE
clone name :
mN1A
reactivity :
mouse
application :
flow cytometry
more info or order :
product information
EntityType :
Monoclonal Antibody
EntityCategory :
Antibodies
ProductCode :
MCA2410PE
Description :
Mouse anti Mouse Notch 1:RPE
Specificity :
Notch 1
TargetSpecies :
Mouse
Host :
Mouse
Format :
RPE
Conjugate/Tag :
RPE
Isotypes :
IgG1
Applications :
F
ApplicationTypes :
Flow Cytometry
CrossReactivities :
Human
Clone :
mN1A
Quantity :
100 Tests
QuantityValue :
100
QuantityType :
Tests
GOAccessions :
GO:0005515,GO:0005509,GO:0001701,GO:0001708,GO:0001837,GO:0001889,GO:0002040,GO:0002051,GO:0003160,GO:0003700,GO:0004872,GO:0005887,GO:0005634,GO:0007368,GO:0007386,GO:0007409,GO:0007440,GO:0007492,GO:0008284,GO:0014807,GO:0021915,GO:0030216,GO:0030324,GO:0030514,GO:0030900,GO:0031069,GO:0031490,GO:0032582,GO:0035116,GO:0042640,GO:0043065,GO:0043066,GO:0043565,GO:0045618,GO:0045668,GO:0046533,GO:0048103,GO:0048663,GO:0048754,GO:0060528,GO:0060740,GO:0060768
GOTerms :
protein binding,calcium ion binding,in utero embryonic development,cell fate specification,epithelial to mesenchymal transition,liver development,sprouting angiogenesis,osteoblast fate commitment,endocardium morphogenesis,sequence-specific DNA binding transcription factor activity,receptor activity,integral to plasma membrane,nucleus,determination of left/right symmetry,compartment pattern formation,axonogenesis,foregut morphogenesis,endoderm development,positive regulation of cell proliferation,regulation of somitogenesis,neural tube development,keratinocyte differentiation,lung development,negative regulation of BMP signaling pathway,forebrain development,hair follicle morphogenesis,chromatin DNA binding,negative regulation of gene-specific transcription,embryonic hindlimb morphogenesis,anagen,positive regulation of apoptosis,negative regulation of apoptosis,sequence-specific DNA binding,positive regulation of keratinocyte differentiation,negative regulation of osteoblast differentiation,negative regulation of photoreceptor cell differentiation,somatic stem cell division,neuron fate commitment,branching morphogenesis of a tube,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,prostate gland epithelium morphogenesis,regulation of epithelial cell proliferation involved in prostate gland development
UniprotAccessions :
Q01705
Gene :
Notch1
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=18128
EntityFormats :
FITC,Purified,RPE
UNSPSC :
41116161
ProductForm :
Purified IgG conjugated to R. Phycoerythrin (RPE) - lyophilized
NotForSaleInCountries :
KR
PriceGBP :
317
PriceEUR :
444
PriceUSD :
455 USD
PriceCHF :
483
PriceSEK :
4951
PriceNOK :
5106
PriceDKK :
3312
more info or order :
company information
Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com
1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.